Capital Fund Management S.A. and Caisse DE Depot ET Placement DU Quebec have reduced their shareholdings in T. Rowe Price Group, Inc. (T. Rowe),
resulting in a sell-off of more than 71,000 shares. However, several other firms, including
Guggenheim Capital LLC, CreativeOne Wealth LLC, and Campbell & CO Investment Adviser LLC, have boosted their positions in T. Rowe. Furthermore, increased stake in T. Rowe was noted by
Firms like Ameriprise Financial Inc., Summit Financial LLC, and Bragg Financial Advisors. The biotech firm recorded a
positive golden cross in its technical outlook, posing a bright future. However, amidst the volatility and analyst divergences, there are
mixed signal around T. Rowe's outlook. Interestingly, T. Rowe's
Q2 earnings surpassed expectations given a high AUM, though revenues fell and the stock price dropped. The firm also
declared a quarterly dividend and experienced a
record $1.70T in Assets as its equity portfolio surged to $859. The
acquisition of senior insurance executives has shaped a new investment narrative for the firm. Finally, the company
recently added two new international equity ETFs to its offerings.
T Rowe Price Group TROW News Analytics from Tue, 11 Mar 2025 07:00:00 GMT to Sat, 30 Aug 2025 20:42:53 GMT -
Rating 3
- Innovation 5
- Information 8
- Rumor -1
